Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 17
1955 41
1956 32
1957 28
1959 16
1960 50
1961 47
1962 24
1963 37
1964 79
1965 51
1966 104
1967 101
1968 104
1969 95
1970 76
1971 90
1972 83
1973 81
1974 72
1975 100
1976 109
1977 115
1978 212
1979 105
1980 110
1981 124
1982 36
1983 113
1984 93
1985 79
1986 74
1987 108
1988 86
1989 89
1990 46
1991 79
1992 62
1993 62
1994 80
1995 54
1996 59
1997 65
1998 52
1999 53
2000 73
2001 72
2002 45
2003 49
2004 49
2005 57
2006 49
2007 47
2008 47
2009 52
2010 49
2011 52
2012 54
2013 60
2014 76
2015 74
2016 92
2017 75
2018 55
2019 40
2020 35
2021 35
2022 27
2023 23
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

4,551 results

Results by year

Filters applied: . Clear all
Page 1
CRISPR/Cas9 Immune System as a Tool for Genome Engineering.
Hryhorowicz M, Lipiński D, Zeyland J, Słomski R. Hryhorowicz M, et al. Arch Immunol Ther Exp (Warsz). 2017 Jun;65(3):233-240. doi: 10.1007/s00005-016-0427-5. Epub 2016 Oct 3. Arch Immunol Ther Exp (Warsz). 2017. PMID: 27699445 Free PMC article. Review.
Immunotherapy in Ovarian Cancer.
Siminiak N, Czepczyński R, Zaborowski MP, Iżycki D. Siminiak N, et al. Arch Immunol Ther Exp (Warsz). 2022 Aug 9;70(1):19. doi: 10.1007/s00005-022-00655-8. Arch Immunol Ther Exp (Warsz). 2022. PMID: 35941287 Free PMC article. Review.
Immunogenicity to biologics: mechanisms, prediction and reduction.
Sethu S, Govindappa K, Alhaidari M, Pirmohamed M, Park K, Sathish J. Sethu S, et al. Arch Immunol Ther Exp (Warsz). 2012 Oct;60(5):331-44. doi: 10.1007/s00005-012-0189-7. Epub 2012 Aug 29. Arch Immunol Ther Exp (Warsz). 2012. PMID: 22930363 Free article. Review.
Heterogeneity in the differentiation and function of CD8⁺ T cells.
Mittrücker HW, Visekruna A, Huber M. Mittrücker HW, et al. Arch Immunol Ther Exp (Warsz). 2014 Dec;62(6):449-58. doi: 10.1007/s00005-014-0293-y. Epub 2014 May 31. Arch Immunol Ther Exp (Warsz). 2014. PMID: 24879097 Free article. Review.
Celiac Disease Autoimmunity.
López Casado MÁ, Lorite P, Ponce de León C, Palomeque T, Torres MI. López Casado MÁ, et al. Arch Immunol Ther Exp (Warsz). 2018 Dec;66(6):423-430. doi: 10.1007/s00005-018-0520-z. Epub 2018 Aug 25. Arch Immunol Ther Exp (Warsz). 2018. PMID: 30167716 Free article.
Skin Immunity.
Matejuk A. Matejuk A. Arch Immunol Ther Exp (Warsz). 2018 Feb;66(1):45-54. doi: 10.1007/s00005-017-0477-3. Epub 2017 Jun 16. Arch Immunol Ther Exp (Warsz). 2018. PMID: 28623375 Free PMC article. Review.
Journal Impact Factor and Self-Citations.
Górski A, Zimecki M, Krotkiewski H. Górski A, et al. Arch Immunol Ther Exp (Warsz). 2021 Aug 2;69(1):21. doi: 10.1007/s00005-021-00621-w. Arch Immunol Ther Exp (Warsz). 2021. PMID: 34338896 No abstract available.
Placebo Controls: Now???
Caplan AI. Caplan AI. Arch Immunol Ther Exp (Warsz). 2021 Mar 29;69(1):9. doi: 10.1007/s00005-021-00612-x. Arch Immunol Ther Exp (Warsz). 2021. PMID: 33782781 Free PMC article. No abstract available.
Heterogeneity Among Neutrophils.
Garley M, Jabłońska E. Garley M, et al. Arch Immunol Ther Exp (Warsz). 2018 Feb;66(1):21-30. doi: 10.1007/s00005-017-0476-4. Epub 2017 May 30. Arch Immunol Ther Exp (Warsz). 2018. PMID: 28560557 Free PMC article. Review.
4,551 results